Castle Biosciences, Inc.
Status: Publicly traded
Direct answer
Castle Biosciences, Inc. is publicly traded on NASDAQ under the ticker CSTL.
Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting various dermatological cancers. Their flagship product, DecisionDx-Melanoma, represents an advanced multi-gene expression profile (GEP) assay engineered to assess the probability of metastasis in patients afflicted with...
Can you invest in Castle Biosciences, Inc.?
Yes. Castle Biosciences, Inc. trades publicly on NASDAQ as CSTL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Castle Biosciences, Inc.
Detailed equity research is provided by MarketSnap.